193 related articles for article (PubMed ID: 18086274)
21. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
Moritani S; Kushima R; Sugihara H; Bamba M; Kobayashi TK; Hattori T
Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
[TBL] [Abstract][Full Text] [Related]
22. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
[TBL] [Abstract][Full Text] [Related]
23. A Comparative Study of Immunohistochemical Myoepithelial Cell Markers in Cutaneous Benign Cystic Apocrine Lesions.
Wood A; Houghton SL; Biswas A
Am J Dermatopathol; 2016 Jul; 38(7):475-83. PubMed ID: 26630681
[TBL] [Abstract][Full Text] [Related]
24. p63 Immunocytochemistry improves accuracy of diagnosis with fine-needle aspiration of the breast.
Harton AM; Wang HH; Schnitt SJ; Jacobs TW
Am J Clin Pathol; 2007 Jul; 128(1):80-5. PubMed ID: 17580273
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
26. Benign apocrine papillary lesions of the breast lacking or virtually lacking myoepithelial cells-potential pitfalls in diagnosing malignancy.
Cserni G
APMIS; 2012 Mar; 120(3):249-52. PubMed ID: 22339683
[TBL] [Abstract][Full Text] [Related]
27. p63 is useful in the diagnosis of mammary metaplastic carcinomas.
Tse GM; Tan PH; Chaiwun B; Putti TC; Lui PC; Tsang AK; Wong FC; Lo AW
Pathology; 2006 Feb; 38(1):16-20. PubMed ID: 16484002
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
29. Fine needle aspiration cytology of papillary lesions of the breast: how accurate is the diagnosis?
Tse GM; Ma TK; Lui PC; Ng DC; Yu AM; Vong JS; Niu Y; Chaiwun B; Lam WW; Tan PH
J Clin Pathol; 2008 Aug; 61(8):945-9. PubMed ID: 18552172
[TBL] [Abstract][Full Text] [Related]
30. Papillary transitional cell carcinoma of the breast: a report of five cases with distinction from eccrine acrospiroma.
Mooney EE; Tavassoli FA
Mod Pathol; 1999 Mar; 12(3):287-94. PubMed ID: 10102614
[TBL] [Abstract][Full Text] [Related]
31. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
Lau SK; Prakash S; Geller SA; Alsabeh R
Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
[TBL] [Abstract][Full Text] [Related]
32. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
[TBL] [Abstract][Full Text] [Related]
33. CD10 and HHF35 actin in the differential diagnosis between Collagenous spherulosis and adenoid-cystic carcinoma of the breast.
Cabibi D; Giannone AG; Belmonte B; Aragona F; Aragona F
Pathol Res Pract; 2012 Jul; 208(7):405-9. PubMed ID: 22658481
[TBL] [Abstract][Full Text] [Related]
34. Loss of myoepithelium is variable in solid papillary carcinoma of the breast.
Nicolas MM; Wu Y; Middleton LP; Gilcrease MZ
Histopathology; 2007 Nov; 51(5):657-65. PubMed ID: 17927587
[TBL] [Abstract][Full Text] [Related]
35. Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy.
Grin A; O'Malley FP; Mulligan AM
Am J Surg Pathol; 2009 Nov; 33(11):1615-23. PubMed ID: 19675450
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic utility of CD10 in benign and malignant extrahepatic bile duct lesions.
Tretiakova M; Antic T; Westerhoff M; Mueller J; Himmelfarb EA; Wang HL; Xiao SY
Am J Surg Pathol; 2012 Jan; 36(1):101-8. PubMed ID: 21989348
[TBL] [Abstract][Full Text] [Related]
37. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A
Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.
Hilson JB; Schnitt SJ; Collins LC
Am J Surg Pathol; 2010 Jun; 34(6):896-900. PubMed ID: 20463570
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
[TBL] [Abstract][Full Text] [Related]
40. Papillary lesions of the breast: selected diagnostic and management issues.
Collins LC; Schnitt SJ
Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]